This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Takeda Pharmaceutical Company Limited, The University of Texas System. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1,229 
1 out of 5,644 
Years Active: 2025
Title: James Wilson Meador, III: Innovator in Cancer Treatment
Introduction
James Wilson Meador, III is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of cancer treatment through his innovative work in chimeric antigen receptors.
Latest Patents
Meador holds a patent for "BCMA chimeric antigen receptors and uses thereof." This patent provides a BCMA targeting chimeric antigen receptor (CAR) that includes a BCMA binding region and an intracellular costimulatory domain derived from DAP10. The application also details engineered immune effector cells, such as NK cells, that incorporate these chimeric antigen receptors. Additionally, it outlines pharmaceutical compositions, kits, and methods for treating cancer.
Career Highlights
Throughout his career, Meador has worked with prominent organizations, including the University of Texas System and Takeda Pharmaceutical Company Limited. His experience in these institutions has allowed him to advance his research and contribute to the development of innovative cancer therapies.
Collaborations
Some of his notable coworkers include Katy Rezvani and Rafet Basar, who have collaborated with him on various projects related to his research.
Conclusion
James Wilson Meador, III is a distinguished inventor whose work in chimeric antigen receptors has the potential to transform cancer treatment. His contributions to the field are invaluable and continue to inspire future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile